$ACGL

Morin Francois sold $1.1M of ACGL

Morin Francois (CFO and Treasurer) sold 11,010 shares of ARCH CAPITAL GROUP LTD. (ACGL) at $99.32 ($1.09M total) on 2026-08-18.

Original reporting
SEC EDGAR · Morin Francois
Published Aug 20, 2026, 8:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACGL
Bearish
medium confidence
Mentioned
$ACGL
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACGLBearishMed
01

Why it matters

The CFO's sale reduces insider ownership, which can be interpreted as a bearish sign by traders.

02

Market read

Insider sales are closely watched; this filing provides fresh data for short‑term positioning.

03

What to watch

No disclosed 10b5‑1 plan; timing may be unrelated to company performance.

Relevance 6/10Novelty 7/10Timing: filing today

Background

Form 4 filing discloses insider transactions; such filings are primary sources of new information.

Company-level read

Ticker impact

$ACGLBearishMedium confidence
Context

CFO Morin Francois sold 11,010 shares for $1.09M, reducing his stake to 184,826 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

The sale size is material for a mid‑cap insurer and the insider holds a key finance role.

Market effects

May raise questions about Arch Capital's financial outlook within the insurance sector.

Limited to U.S. listed insurers; no broader regional effect.

Low global relevance.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Arch Capital Group Ltd.

    Insurance and reinsurance firm listed on NYSE.

  • Morin Francois

    Chief Financial Officer and Treasurer of Arch Capital.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACGLMed

Arch Capital Group Ltd. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics Management characterizes the current environment as the early stages of a softening market, driven by an influx of capacity in property and short-tail lines. Insurance segment performance was impacted by catastrophe losses from the Iran conflict, though underlying results remain strong with a 91.6% current accident year ex-cat combined ratio.

$ACGLMed

Arch Capital Q2 underwriting income falls 20% on cat losses

Arch Capital Group reported Q2 2026 underwriting income down 19.7% to $657 million, with the consolidated combined ratio at 83.5% as catastrophe losses lifted the loss ratio to 55.1%. Net premiums written fell 6.9% to $4.05 billion. Net income to common shareholders was $1.05 billion, or $3.00 per diluted share. The company repurchased $1.2 billion of shares.

$ACGLMed

Arch posts $1b profit despite $200m catastrophe hit

Arch Capital Group reported Q2 net income of $1.047 billion ($3.00 per diluted share), down 14.6% YoY. Underwriting income fell 19.7% to $657 million as the combined ratio rose to 83.5%. The company absorbed $201 million of catastrophe losses and repurchased $1.2 billion of shares. Gross premiums written slipped to $6.13 billion.